312 related articles for article (PubMed ID: 30395140)
1. Clinical characteristics and outcome of lone atrial fibrillation at a tertiary referral centre: the Groote Schuur Hospital experience.
Thomas V; Schulein S; Millar RN; Mayosi BM
Cardiovasc J Afr; 2018; 29(5):268-272. PubMed ID: 30395140
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes of atrial fibrillation and flutter at the Aga Khan University Hospital, Nairobi.
Shavadia J; Yonga G; Mwanzi S; Jinah A; Moriasi A; Otieno H
Cardiovasc J Afr; 2013 Mar; 24(2):6-9. PubMed ID: 23612946
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study.
Chen YL; Lin YS; Wang HT; Liu WH; Chen HC; Chen MC
Europace; 2019 Feb; 21(2):313-321. PubMed ID: 30107472
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department.
Hamilton A; Clark D; Gray A; Cragg A; Grubb N;
Eur J Emerg Med; 2015 Jun; 22(3):155-61. PubMed ID: 25203594
[TBL] [Abstract][Full Text] [Related]
5. A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study.
Potpara TS; Stankovic GR; Beleslin BD; Polovina MM; Marinkovic JM; Ostojic MC; Lip GYH
Chest; 2012 Feb; 141(2):339-347. PubMed ID: 21622553
[TBL] [Abstract][Full Text] [Related]
6. Risk of atrial fibrillation after atrial flutter ablation: impact of AF history, gender, and antiarrhythmic drug medication.
Brembilla-Perrot B; Girerd N; Sellal JM; Olivier A; Manenti V; Villemin T; Beurrier D; DE Chillou C; Louis P; Selton O; DE LA Chaise AT
J Cardiovasc Electrophysiol; 2014 Aug; 25(8):813-820. PubMed ID: 24654647
[TBL] [Abstract][Full Text] [Related]
7. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
[TBL] [Abstract][Full Text] [Related]
8. Prolonged atrial effective refractory periods in atrial fibrillation patients associated with structural heart disease or sinus node dysfunction compared with lone atrial fibrillation.
Uhm JS; Mun HS; Wi J; Shim J; Joung B; Lee MH; Pak HN
Pacing Clin Electrophysiol; 2013 Feb; 36(2):163-71. PubMed ID: 23121003
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
[TBL] [Abstract][Full Text] [Related]
10. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
[No Abstract] [Full Text] [Related]
11. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
Vora AN; Dai D; Matsuoka R; Harrison JK; Hughes GC; Sherwood MW; Piccini JP; Bhardwaj B; Lopes RD; Cohen D; Holmes DR; Thourani VH; Peterson E; Kirtane A; Kapadia S; Vemulapalli S
JACC Cardiovasc Interv; 2018 Sep; 11(17):1746-1756. PubMed ID: 30190063
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease.
Banchs JE; Baquero GA; Nickolaus MJ; Wolbrette DL; Kelleman JJ; Samii S; Grando-Ting J; Penny-Peterson E; Davidson WR; Young SK; Naccarelli GV; Gonzalez MD
Congenit Heart Dis; 2014; 9(3):221-7. PubMed ID: 23947935
[TBL] [Abstract][Full Text] [Related]
13. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry.
Chiang CE; Naditch-Brûlé L; Murin J; Goethals M; Inoue H; O'Neill J; Silva-Cardoso J; Zharinov O; Gamra H; Alam S; Ponikowski P; Lewalter T; Rosenqvist M; Steg PG
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):632-9. PubMed ID: 22787011
[TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic and electrophysiological characteristics of atrial fibrillation organized into atrial flutter by oral administration of class I antiarrhythmic agents.
Ohmura K; Kobayashi Y; Miyauchi Y; Endoh Y; Atarashi H; Katoh T; Takano T
Pacing Clin Electrophysiol; 2003 Mar; 26(3):692-702. PubMed ID: 12698669
[TBL] [Abstract][Full Text] [Related]
15. Long-term Prognosis of Paroxysmal Atrial Fibrillation and Predictors for Progression to Persistnt or Chronic Atrial Fibrillation in the Korean Population.
Im SI; Chun KJ; Park SJ; Park KM; Kim JS; On YK
J Korean Med Sci; 2015 Jul; 30(7):895-902. PubMed ID: 26130952
[TBL] [Abstract][Full Text] [Related]
16. Clinical Differences between Subtypes of Atrial Fibrillation and Flutter: Cross-Sectional Registry of 407 Patients.
Almeida ED; Guimarães RB; Stephan LS; Medeiros AK; Foltz K; Santanna RT; Pires LM; Kruse ML; Lima GG; Leiria TL
Arq Bras Cardiol; 2015 Jul; 105(1):3-10. PubMed ID: 26016782
[TBL] [Abstract][Full Text] [Related]
17. The natural history of lone atrial flutter.
Halligan SC; Gersh BJ; Brown RD; Rosales AG; Munger TM; Shen WK; Hammill SC; Friedman PA
Ann Intern Med; 2004 Feb; 140(4):265-8. PubMed ID: 14970149
[TBL] [Abstract][Full Text] [Related]
18. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
20. [The prevention of paroxysmal atrial fibrillation complicating the course of sick sinus syndrome].
Tatarchenko IP; Oleĭnikov VE; Rakhmatullov FK
Kardiologiia; 1993; 33(11):55-7. PubMed ID: 8145425
[No Abstract] [Full Text] [Related]
[Next] [New Search]
